Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care

BACKGROUND: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and death. Drug use remains the significant cause of new infections in the European Union, with estimates of HCV antibody prevalence among people who inject drugs ranging from 5% to 90% in 29 European countries....

Descripción completa

Detalles Bibliográficos
Autores principales: McCombe, Geoff, Swan, Davina, O’Connor, Eileen, Avramovic, Gordana, Vickerman, Peter, Ward, Zoe, Surey, Julian, Macías, Juan, Lambert, John S, Cullen, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006011/
https://www.ncbi.nlm.nih.gov/pubmed/29866641
http://dx.doi.org/10.2196/resprot.9043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006011/
https://www.ncbi.nlm.nih.gov/pubmed/29866641
http://dx.doi.org/10.2196/resprot.9043

Ejemplares similares